Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic

Anixa Biosciences reveals final data from Phase one clinical trial of investigational breast cancer vaccine at 2025 San Antonio Breast Cancer Symposium

Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio

Yuyu Pharma invests in Dalan Animal Health

Avetra unveils site-centric CRO operating model

Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15

Lunai Bioworks receives first LOI to license next-generation immune cell therapy

BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU

Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s

ExpreS2ion Biotech signs definitive licensing deal with Serum Institute of India for novel malaria vaccines

PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt

Lunai Bioworks publishes breakthrough on second-generation allogeneic dendritic cell therapy in vaccines

Frontier IP portfolio company achieves breakthrough in livestock vaccine trials

GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine

Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses